EXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
General Surgeon
2012 - 2019, Diyarbakır/Diyarbakır/Turkey
DİCLE UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2011 - 2012, Van/Van/Turkey
VAN REGIONAL TRAINING AND RESEARCH HOSPITAL
General Surgeon
2009 - 2011, Van/Van/Turkey
HAKKARİ STATE HOSPITAL
General Surgeon
2004 - 2009, Van/Van/Turkey
YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2002 - 2004, Van/Van/Turkey
HACIBEKİR HEALTH CENTER
General Practitioner
*EDUCATION*
2018 - 2019, Diyarbakır/Turkey
Associate Professor
2015, Ohio/USA
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
Neck Dissection Training
2012 - 2018, Diyarbakır/Turkey
Assistant Professor
1996 - 2002, Adana/Turkey
ÇUKUROVA UNIVERSITY
FACULTY OF MEDICINE - Medical Doctor Education
Mehr lesenEXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
General Surgeon
2012 - 2019, Diyarbakır/Diyarbakır/Turkey
DİCLE UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2011 - 2012, Van/Van/Turkey
VAN REGIONAL TRAINING AND RESEARCH HOSPITAL
General Surgeon
2009 - 2011, Van/Van/Turkey
HAKKARİ STATE HOSPITAL
General Surgeon
2004 - 2009, Van/Van/Turkey
YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2002 - 2004, Van/Van/Turkey
HACIBEKİR HEALTH CENTER
General Practitioner
*EDUCATION*
2018 - 2019, Diyarbakır/Turkey
Associate Professor
2015, Ohio/USA
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
Neck Dissection Training
2012 - 2018, Diyarbakır/Turkey
Assistant Professor
1996 - 2002, Adana/Turkey
ÇUKUROVA UNIVERSITY
FACULTY OF MEDICINE - Medical Doctor Education
*EXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
Ophthalmologist
2016 - 2019, Istanbul/Istanbul/Turkey
BEZMİALEM UNIVERSITY FACULTY OF MEDICINE
Assistant Professor
2015 - 2016, Istanbul/Istanbul/Turkey
SB HASEKİ TRAINING AND RESEARCH HOSPITAL
Educator
2008 - 2015, Sivas/Sivas/Turkey
CUMHURIYET UNIVERSITY FACULTY OF MEDICINE HOSPITAL
Chairman of the Department of Ophthalmology
1995 - 2008, Sivas/Sivas/Turkey
CUMHURIYET UNIVERSITY FACULTY OF MEDICINE
Faculty Member
1989 - 1990, Sivas/Sivas/Turkey
HEALTH CENTER NO.1
General Practitioner
*EDUCATION*
2008
Professor
2002
Associate Professor
1990 - 1994, Sivas/Turkey
CUMHURIYET UNIVERSITY FACULTY OF MEDICINE
Ophthalmology Residency Training
1983 - 1989, Adana/Turkey
ÇUKUROVA UNIVERSITY FACULTY OF MEDICINE
Medical Doctor Education
Mehr lesen
*EXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
Ophthalmologist
2016 - 2019, Istanbul/Istanbul/Turkey
BEZMİALEM UNIVERSITY FACULTY OF MEDICINE
Assistant Professor
2015 - 2016, Istanbul/Istanbul/Turkey
SB HASEKİ TRAINING AND RESEARCH HOSPITAL
Educator
2008 - 2015, Sivas/Sivas/Turkey
CUMHURIYET UNIVERSITY FACULTY OF MEDICINE HOSPITAL
Chairman of the Department of Ophthalmology
1995 - 2008, Sivas/Sivas/Turkey
CUMHURIYET UNIVERSITY FACULTY OF MEDICINE
Faculty Member
1989 - 1990, Sivas/Sivas/Turkey
HEALTH CENTER NO.1
General Practitioner
*EDUCATION*
2008
Professor
2002
Associate Professor
1990 - 1994, Sivas/Turkey
CUMHURIYET UNIVERSITY FACULTY OF MEDICINE
Ophthalmology Residency Training
1983 - 1989, Adana/Turkey
ÇUKUROVA UNIVERSITY FACULTY OF MEDICINE
Medical Doctor Education
Experience
2018
Private Istanbul Medipol Hospital
2018
Medipol University Camlica Hospital
2018
Medipol Camlica Hospital
2013 - 2018
Medipol Mega University Hospital
2011 - 2013
Yuzuncu Yil University Hospital
2010 - 2011
Gulhane Military Medical Academy
2010 - 2013
Yuzuncu Yil University Hospital
2010 - 2011
Gulhane Military Medical Academy
2010 - 2011
Gulhane Military Medical Academy
2010 - 2013
Yuzuncu Yil University Faculty of Medicine
2009
University of Toronto SickKids Hospital
2004 - 2008
Private Van-Etfal Pediatric Diseases
1999 - 2004
Yuzuncu Yil University Hospital
Education
2010
Yuzuncu Yil University, Pediatric Nephrology
2004
Yuzuncu Yil University, Pediatrics
1998
Ege University, Faculty of Medicine
Mehr lesen
Experience
2018
Private Istanbul Medipol Hospital
2018
Medipol University Camlica Hospital
2018
Medipol Camlica Hospital
2013 - 2018
Medipol Mega University Hospital
2011 - 2013
Yuzuncu Yil University Hospital
2010 - 2011
Gulhane Military Medical Academy
2010 - 2013
Yuzuncu Yil University Hospital
2010 - 2011
Gulhane Military Medical Academy
2010 - 2011
Gulhane Military Medical Academy
2010 - 2013
Yuzuncu Yil University Faculty of Medicine
2009
University of Toronto SickKids Hospital
2004 - 2008
Private Van-Etfal Pediatric Diseases
1999 - 2004
Yuzuncu Yil University Hospital
Education
2010
Yuzuncu Yil University, Pediatric Nephrology
2004
Yuzuncu Yil University, Pediatrics
1998
Ege University, Faculty of Medicine
Experience
2019 - 2022 Medipol University
2010 Private Nisa Hospital
2008 - 2010 Kaman State Hospital
Education
2008
Istanbul University Cerrahpaşa Faculty of Medicine, Obstetrics and Gynecology
2002
Istanbul University, Istanbul Faculty of Medicine
Mehr lesenExperience
2019 - 2022 Medipol University
2010 Private Nisa Hospital
2008 - 2010 Kaman State Hospital
Education
2008
Istanbul University Cerrahpaşa Faculty of Medicine, Obstetrics and Gynecology
2002
Istanbul University, Istanbul Faculty of Medicine
2023 - Halen, Antalya/Türkiye
MEMORIAL ANTALYA HASTANESİ
Üroloji Uzmanı
2020 - 2022, Antalya/Türkiye
MEDSTAR TOPÇULAR HASTANESİ
Üroloji Uzmanı
2016 - 2020, Antalya/Türkiye
MEDICAL PARK ANTALYA HASTANESİ
Üroloji Uzmanı
2007 - 2016, Antalya/Türkiye
YAŞAM HASTANESİ
Üroloji Uzmanı
1991 - 2006, Antalya/Türkiye
AKDENİZ ÜNİVERSİTESİ TIP FAKÜLTESİ
Üroloji Uzmanı
Mehr lesen2023 - Halen, Antalya/Türkiye
MEMORIAL ANTALYA HASTANESİ
Üroloji Uzmanı
2020 - 2022, Antalya/Türkiye
MEDSTAR TOPÇULAR HASTANESİ
Üroloji Uzmanı
2016 - 2020, Antalya/Türkiye
MEDICAL PARK ANTALYA HASTANESİ
Üroloji Uzmanı
2007 - 2016, Antalya/Türkiye
YAŞAM HASTANESİ
Üroloji Uzmanı
1991 - 2006, Antalya/Türkiye
AKDENİZ ÜNİVERSİTESİ TIP FAKÜLTESİ
Üroloji Uzmanı
Experience
Liman Hospital Radiology Clinic
Academy Medical Center
Anaclinic Medical Center
Kayseri State Hospital
Kayseri Erciyes University Radiology Clinic
Samsun Private Midiliv Medical Center
Samsun Büyük Anadolu Hospital (2023)
Mehr lesen
Experience
Liman Hospital Radiology Clinic
Academy Medical Center
Anaclinic Medical Center
Kayseri State Hospital
Kayseri Erciyes University Radiology Clinic
Samsun Private Midiliv Medical Center
Samsun Büyük Anadolu Hospital (2023)
Specializations
Abdomen Radiology
Doppler Radiology
Obstetric Radiology
Breast Radiology
Musculoskeletal Radiology
Pediatric Radiology
Neuroradiology
Nonvascular Interventional Procedures
Mehr lesen
Specializations
Abdomen Radiology
Doppler Radiology
Obstetric Radiology
Breast Radiology
Musculoskeletal Radiology
Pediatric Radiology
Neuroradiology
Nonvascular Interventional Procedures
Specializations
Mehr lesen
Specializations
uzmanlık
Mehr lesen
uzmanlık
Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Mehr lesenEducation:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Specializations
Diabetes (Sugar)
Thyroid
Hypertension
cholesterol
stomach diseases
intestinal diseases
osteoporosis
Experience
Azerbaijan Gusar Central Hospital
Vreden Russian Research Institute of Traumatology and Orthopedics
Azerbaijan Göranboy, First Lieutenant Doctor
Hospital Park Darıca Hospital
BAH
Education
Azerbaijan Medical Faculty (2015)
Kocaeli Derince Training and Research Hospital (2016-2020)
Vocational Trainings, Courses and Conferences Attended
Internal Medicine Congress
Gastro Academy
Mehr lesenSpecializations
Diabetes (Sugar)
Thyroid
Hypertension
cholesterol
stomach diseases
intestinal diseases
osteoporosis
Experience
Azerbaijan Gusar Central Hospital
Vreden Russian Research Institute of Traumatology and Orthopedics
Azerbaijan Göranboy, First Lieutenant Doctor
Hospital Park Darıca Hospital
BAH
Education
Azerbaijan Medical Faculty (2015)
Kocaeli Derince Training and Research Hospital (2016-2020)
Vocational Trainings, Courses and Conferences Attended
Internal Medicine Congress
Gastro Academy
Medical Interests
Interventional Bronchoscopy
Respiratory Deficiencies
Rare diseases of the lung
Interstitial lung diseases
Psychoneuroimmunology
Medical Fitness and nutrition
Education
Bachelor’s: Istanbul University / Istanbul Faculty of Medicine / 1988-1997
Specialization in Medicine: Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / Chest Diseases and Tuberculosis / 2001-2006 The Importance and Value of CA-125 in the Diagnosis of Tuberculosis Pleurisy / Assoc. Sedat Altın - Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital
Experience
Dr. / Ayazağa MCHFP / 1997-2001
Assist. Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / 2001-2006
Res. See. / Hopital St-Marguerite Center Laser / 2004
Res. See. / University de St-Etienne, Faculte de Medecin, Pneumologie et Oncologie Thoracique / 2005
Dr. / Bozüyük State Hospital / 2006-2008
Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Interventional Pulmonology Unit / 2008-2012
Dr. / Zürich University Faculty of Medicine, Lung Transplantation Unit / 2009-2010
Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Respiratory Intensive Care Unit / 2010-2012
Assoc. Dr / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2013- 2017
Prof. Dr. / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2017-2018 • prof. Dr. / Memorial Bahçelievler Hospital / 2018-2018
Prof. Dr. Demiroglu Science Un. Faculty of Medicine Chest Diseases USA-Istanbul / 2018-2020 Florence Nightingale Hospital
Prof. Dr. / Memorial Bahçelievler and Şişli Hospitals / 2020-2021
Liv Hospital Vadistanbul / 2021 -
Memberships
European Respiratory Society (ERS)
European Association of Bronchology and Interventional Pulmonology (EABIP)
Societé de Pnemologie de langue Française (SPLF)
Groupe d’Endoscopie de langue française (GELF)
Mehr lesenMedical Interests
Interventional Bronchoscopy
Respiratory Deficiencies
Rare diseases of the lung
Interstitial lung diseases
Psychoneuroimmunology
Medical Fitness and nutrition
Education
Bachelor’s: Istanbul University / Istanbul Faculty of Medicine / 1988-1997
Specialization in Medicine: Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / Chest Diseases and Tuberculosis / 2001-2006 The Importance and Value of CA-125 in the Diagnosis of Tuberculosis Pleurisy / Assoc. Sedat Altın - Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital
Experience
Dr. / Ayazağa MCHFP / 1997-2001
Assist. Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital / 2001-2006
Res. See. / Hopital St-Marguerite Center Laser / 2004
Res. See. / University de St-Etienne, Faculte de Medecin, Pneumologie et Oncologie Thoracique / 2005
Dr. / Bozüyük State Hospital / 2006-2008
Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Interventional Pulmonology Unit / 2008-2012
Dr. / Zürich University Faculty of Medicine, Lung Transplantation Unit / 2009-2010
Dr. / Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Respiratory Intensive Care Unit / 2010-2012
Assoc. Dr / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2013- 2017
Prof. Dr. / I. Bilim University Faculty of Medicine Department of Chest Diseases / 2017-2018 • prof. Dr. / Memorial Bahçelievler Hospital / 2018-2018
Prof. Dr. Demiroglu Science Un. Faculty of Medicine Chest Diseases USA-Istanbul / 2018-2020 Florence Nightingale Hospital
Prof. Dr. / Memorial Bahçelievler and Şişli Hospitals / 2020-2021
Liv Hospital Vadistanbul / 2021 -
Memberships
European Respiratory Society (ERS)
European Association of Bronchology and Interventional Pulmonology (EABIP)
Societé de Pnemologie de langue Française (SPLF)
Groupe d’Endoscopie de langue française (GELF)
Experience
2018 - 2022
Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital
2016 - 2018
Diyarbakır Memorial Dicle Hospital Cardiology Clinic
2010 - 2010
Dicle University Faculty of Medicine, Department of Cardiology
2010 - 2016
Private Veni Vidi Hospital, Cardiology Clinic Supervisor
2006 - 2010
Dicle University Faculty of Medicine, Department of Cardiology
2005 - 2006
Urfa State Hospital
1999 - 2005
Turkey High Specialization Training and Research Hospital
1998 - 1999
Duruca Health Center
Education
2018
Health Sciences University, Cardiology
2010
Dicle University, Department of Cardiology
2005
Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization
1998
Ege University, Faculty of Medicine
Mehr lesenExperience
2018 - 2022
Health Sciences University – Şişli Hamidiye Etfal Training and Research Hospital
2016 - 2018
Diyarbakır Memorial Dicle Hospital Cardiology Clinic
2010 - 2010
Dicle University Faculty of Medicine, Department of Cardiology
2010 - 2016
Private Veni Vidi Hospital, Cardiology Clinic Supervisor
2006 - 2010
Dicle University Faculty of Medicine, Department of Cardiology
2005 - 2006
Urfa State Hospital
1999 - 2005
Turkey High Specialization Training and Research Hospital
1998 - 1999
Duruca Health Center
Education
2018
Health Sciences University, Cardiology
2010
Dicle University, Department of Cardiology
2005
Cardiology Turkey High Specialization Training and Research Hospital, Medical Specialization
1998
Ege University, Faculty of Medicine
Experience
2017 - 2019 Okan Üniversitesi Hastanesi
2019 - Medipol University Pendik Hospital
Education
2016 Marmara Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları
2007 Aziz Kiril ve Metodiy Üniversitesi, Tıp Fakültesi
Publications
1- Yetişkin Kistik Fibrozis Dışı Bronşektazi Hastalarında İmmün Yetmezlik Sıklığı ; Uzmanlık Tezi
2- Canan Cimşit, Melahat Bekir, Sait Karakurt, Emel Eryüksel, KOAH’ta diyafram kalınlığının ultrasonografi ile değerlendirilmesi – Marmara Medical Journal 2016; 29:8-13
3- Emel Eryuksel, Canan Cimsit , Melahat Bekir, Çagatay Cimsit , Sait Karakurt, Diaphragmatic Thickness Fraction in Subjects at High Risk for COPD Exacerbations Respiratory Care December 2017
4- Melahat Bekir ,T. Bahadır Üskül, Pulmonary Functions in Patients With Idiopathic Scoliosis The Journal of Turkish Spinal Surgery ; April 2017
5- Emel Eryuksel , Canan Cimsit, Melahat Bekir, Cagatay Cimşit, Sait Karakurt, Is Diaphragmatic Thickness fraction valuable in Identifying High- Risk Chronic Obstructive Pulmonary Disease Patients , European Respiratory Journal Sep 2017
6- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Berrin Ceyhan, Kistik Fibrozis Dışı Erişkin Bronşektazi Hastalarında Klinik Bulguların Bir Yıllık Hastalık Seyrine Etkisi Türk Toraks Derneği 21. Yıllık Kongresi _ Belek, Türkiye 2018
7- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli Derya Kocakaya, Emel Eryüksel, Elif Karakoç Aydıner, İsmail Öğülür, Berrin Bağcı Ceyhan, Kistik Fibrozis Dışı Erişkin Bronşektazi Hastalarında Yaşam Kalitesi : Psikolojik durum ve Hastalık Şiddetinin Rolü Türk Toraks Derneği 20. Yıllık Kongresi – Belek Türkiye 2017
8- Berrin Ceyhan, Melahat Bekir, Şehnaz olgun Yıldızeli, Derya Kocakaya , Emel Eryüksel, EMBARC ( Eurpean Bronchiectasis Audit and Reserach Collaboration) yaşam kalitesi ölçeğinin Türkçe versiyonunun kistik fibrozis dışı bronşektazi hastarında geçerlik ve güvenirliği Türk Toraks Derneği 20. Yıllık Kongresi – Belek, Türkiye 2017 ( POSTER ÖDÜLLÜ)
9- Melahat Bekir, Şehnaz Olgun Yıldizeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Beyhan , Yetişkin Non Kistik Fibrozis Bronşektazi Hastalarında Vitamin D düzeyi ile Akciğer Fonksiyonları, Klinik İndeksler, Anksiyete- Depresyon Semptomları Arasındaki İlişki – Türk Toraks Derneği 19. Yıllık Kongresi - Belek, Türkiye 2016
10- Melahat Bekir, Derya Kocakaya , Şehnaz Olgun , Berrin Bağcı Ceyhan , Aktif Kanaması Olan Vena Cava Superior Sendromuna Yol Açan Venöz Tromboz Olgusunda Antikoagülan Tedavi Yaklaşımı – Türk Toraks Derneği 18. Yıllık Kongresi – Belek, Türkiye 2015
11- Melahat Bekir, Berrin Bağcı Ceyhan, Rivaroxaban ile Antikoagülasyon Sonrası Gelişen Hayattı Tehdit Eden Kanamalar : İki Olgu Sunumu , Türk Toraks Derneği 18. Yıllık Kongresi – Belek, Türkiye 2015
12- Şehnaz Olgun Yıldızeli, Çagatay Nuri Cimşit, Semiha Emel Eryüksel, Canan Cimşit, Melahat Bekir, Tuğçe Yakut, Pulmoner Embolide Pulmoner BT Anjionun Klinik Skorlamalar ile İlişkisi – Türk Toraks Derneği 18. Yıllık Kongresi – Belek Türkiye 2015
13- Melahat Bekir, Canan Cimşit, Hüseyin Arıkan, Derya Kocakaya, Şehnaz,Olgun, Semiha Emel Eryüksel, Sait Karakurt, KOAH Hastalarında Diyafram Kalınlığı ve Semptomlarla İlişkisi, Türk Toraks Derneği 17. Yıllık Kongresi – Belek, Türkiye 2014
14- Melahat Bekir Külah, Kistik Fibrozis Dışı Bronşektazi Hastalarında İmmün yetmezlik Sıklığı ve Klinik Parametrelerle İlişkisi Türk Toraks Derneği 20. Yıllık Kongresi – Belek Türkiye 2017
15- Berrin Ceyhan, Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya , One Year Follow-Up of respiratory Health Outcomes in adult patiens with Non- Cystic Fibrosis Bronchiectasis ERS 2018
16- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Emel Eryüksel, Elif Karakoç, İsmail Öğülür Berrin Bağcı Ceyhan Immun Deficiency in Patients with Non Cystic Fibrosis Bronchiectasis and Relationship with Clinical Parameters ATS Conference 2017- Washington, DC 2017
17- Melahat Bekir Külah, Sehnaz Olgun Yildizeli, Derya Kocakaya, Emel Eryuksel, Berrin Bagci Ceyhan Health Related Quality of Life Among Adult Patients With non Cf Bronchiectasis : The Role of Psychological status and disease severity ERS İnternatıonal Congress 2017 , Milan Italy 2017
18- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Ceyhan The Relationship Between Vitamin D Level and Lunf Fonction, Severity and Clinical Indices, Depression and Anxiety Symptoms in Adult Patients With Non- Cystic Fibrosis Bronchiectasis ATS Conference 2016 - San Francisco , California 2016
Mehr lesenExperience
2017 - 2019 Okan Üniversitesi Hastanesi
2019 - Medipol University Pendik Hospital
Education
2016 Marmara Üniversitesi Tıp Fakültesi, Göğüs Hastalıkları
2007 Aziz Kiril ve Metodiy Üniversitesi, Tıp Fakültesi
Publications
1- Yetişkin Kistik Fibrozis Dışı Bronşektazi Hastalarında İmmün Yetmezlik Sıklığı ; Uzmanlık Tezi
2- Canan Cimşit, Melahat Bekir, Sait Karakurt, Emel Eryüksel, KOAH’ta diyafram kalınlığının ultrasonografi ile değerlendirilmesi – Marmara Medical Journal 2016; 29:8-13
3- Emel Eryuksel, Canan Cimsit , Melahat Bekir, Çagatay Cimsit , Sait Karakurt, Diaphragmatic Thickness Fraction in Subjects at High Risk for COPD Exacerbations Respiratory Care December 2017
4- Melahat Bekir ,T. Bahadır Üskül, Pulmonary Functions in Patients With Idiopathic Scoliosis The Journal of Turkish Spinal Surgery ; April 2017
5- Emel Eryuksel , Canan Cimsit, Melahat Bekir, Cagatay Cimşit, Sait Karakurt, Is Diaphragmatic Thickness fraction valuable in Identifying High- Risk Chronic Obstructive Pulmonary Disease Patients , European Respiratory Journal Sep 2017
6- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Berrin Ceyhan, Kistik Fibrozis Dışı Erişkin Bronşektazi Hastalarında Klinik Bulguların Bir Yıllık Hastalık Seyrine Etkisi Türk Toraks Derneği 21. Yıllık Kongresi _ Belek, Türkiye 2018
7- Melahat Bekir Külah, Şehnaz Olgun Yıldızeli Derya Kocakaya, Emel Eryüksel, Elif Karakoç Aydıner, İsmail Öğülür, Berrin Bağcı Ceyhan, Kistik Fibrozis Dışı Erişkin Bronşektazi Hastalarında Yaşam Kalitesi : Psikolojik durum ve Hastalık Şiddetinin Rolü Türk Toraks Derneği 20. Yıllık Kongresi – Belek Türkiye 2017
8- Berrin Ceyhan, Melahat Bekir, Şehnaz olgun Yıldızeli, Derya Kocakaya , Emel Eryüksel, EMBARC ( Eurpean Bronchiectasis Audit and Reserach Collaboration) yaşam kalitesi ölçeğinin Türkçe versiyonunun kistik fibrozis dışı bronşektazi hastarında geçerlik ve güvenirliği Türk Toraks Derneği 20. Yıllık Kongresi – Belek, Türkiye 2017 ( POSTER ÖDÜLLÜ)
9- Melahat Bekir, Şehnaz Olgun Yıldizeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Beyhan , Yetişkin Non Kistik Fibrozis Bronşektazi Hastalarında Vitamin D düzeyi ile Akciğer Fonksiyonları, Klinik İndeksler, Anksiyete- Depresyon Semptomları Arasındaki İlişki – Türk Toraks Derneği 19. Yıllık Kongresi - Belek, Türkiye 2016
10- Melahat Bekir, Derya Kocakaya , Şehnaz Olgun , Berrin Bağcı Ceyhan , Aktif Kanaması Olan Vena Cava Superior Sendromuna Yol Açan Venöz Tromboz Olgusunda Antikoagülan Tedavi Yaklaşımı – Türk Toraks Derneği 18. Yıllık Kongresi – Belek, Türkiye 2015
11- Melahat Bekir, Berrin Bağcı Ceyhan, Rivaroxaban ile Antikoagülasyon Sonrası Gelişen Hayattı Tehdit Eden Kanamalar : İki Olgu Sunumu , Türk Toraks Derneği 18. Yıllık Kongresi – Belek, Türkiye 2015
12- Şehnaz Olgun Yıldızeli, Çagatay Nuri Cimşit, Semiha Emel Eryüksel, Canan Cimşit, Melahat Bekir, Tuğçe Yakut, Pulmoner Embolide Pulmoner BT Anjionun Klinik Skorlamalar ile İlişkisi – Türk Toraks Derneği 18. Yıllık Kongresi – Belek Türkiye 2015
13- Melahat Bekir, Canan Cimşit, Hüseyin Arıkan, Derya Kocakaya, Şehnaz,Olgun, Semiha Emel Eryüksel, Sait Karakurt, KOAH Hastalarında Diyafram Kalınlığı ve Semptomlarla İlişkisi, Türk Toraks Derneği 17. Yıllık Kongresi – Belek, Türkiye 2014
14- Melahat Bekir Külah, Kistik Fibrozis Dışı Bronşektazi Hastalarında İmmün yetmezlik Sıklığı ve Klinik Parametrelerle İlişkisi Türk Toraks Derneği 20. Yıllık Kongresi – Belek Türkiye 2017
15- Berrin Ceyhan, Melahat Bekir Külah, Şehnaz Olgun Yıldızeli, Derya Kocakaya , One Year Follow-Up of respiratory Health Outcomes in adult patiens with Non- Cystic Fibrosis Bronchiectasis ERS 2018
16- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Emel Eryüksel, Elif Karakoç, İsmail Öğülür Berrin Bağcı Ceyhan Immun Deficiency in Patients with Non Cystic Fibrosis Bronchiectasis and Relationship with Clinical Parameters ATS Conference 2017- Washington, DC 2017
17- Melahat Bekir Külah, Sehnaz Olgun Yildizeli, Derya Kocakaya, Emel Eryuksel, Berrin Bagci Ceyhan Health Related Quality of Life Among Adult Patients With non Cf Bronchiectasis : The Role of Psychological status and disease severity ERS İnternatıonal Congress 2017 , Milan Italy 2017
18- Melahat Bekir, Şehnaz Olgun Yıldızeli, Derya Kocakaya, Hüseyin Arıkan, Emel Eryüksel, Berrin Bağcı Ceyhan The Relationship Between Vitamin D Level and Lunf Fonction, Severity and Clinical Indices, Depression and Anxiety Symptoms in Adult Patients With Non- Cystic Fibrosis Bronchiectasis ATS Conference 2016 - San Francisco , California 2016
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Mehr lesen
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences